Myocardial Connective Tissue Growth Factor (CCN2/CTGF) Attenuates Left Ventricular Remodeling after Myocardial Infarction

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Gravning, Jørgen ^a,b   Ørn, Stein ^c   Kaasbøll, Ole Jørgen ^a,b   Martinov, Vladimir N ^a,b   Manhenke, Cord ^c   Dickstein, Kenneth ^c,d   Edvardsen, Thor ^a,b   Attramadal, Håvard ^a,b   Ahmed, Mohammed Shakil ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c STAVANGER UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF BERGEN   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CONNECTIVE TISSUE GROWTH FACTOR; GROWTH DIFFERENTIATION FACTOR 15;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTERY LIGATION; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR MORTALITY; CELL COUNT; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEALING; HEART DISEASE; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE DILATATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; HUMAN; HUMAN CELL; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LEUKOCYTE; MACROPHAGE; MALE; NONHUMAN; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDY; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SCAR; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TREATMENT OUTCOME;

ANIMALS; APOPTOSIS; C-REACTIVE PROTEIN; CARDIOMEGALY; CONNECTIVE TISSUE GROWTH FACTOR; DISEASE MODELS, ANIMAL; FEMALE; FIBROSIS; GROWTH DIFFERENTIATION FACTOR 15; HEART FAILURE; HUMANS; KI-67 ANTIGEN; MALE; MICE; MICE, TRANSGENIC; MICROVESSELS; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIUM; PROTO-ONCOGENE PROTEINS C-KIT; VENTRICULAR REMODELING;

ANIMALIA; MUS; MUS MUSCULUS;

EID: 84871416039     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0052120     Document Type: Article

References (25)

1. Ørn S, Manhenke C, Anand IS, Squire I, Nagel E, et al. (2007) Effect of left ventricular scar size, location, and transmurality on left ventricular remodeling with healed myocardial infarction. Am J Cardiol 99: 1109-1114.
2. Ahmed MS, Øie E, Vinge LE, Yndestad A, Andersen GØ, et al. (2004) Connective tissue growth factor- a novel mediator of angiotensin II-stimulated cardiac fibroblast activation in heart failure in rats. J Mol Cell Cardiol 36: 393-404.
3. Chen MM, Lam A, Abraham JA, Schreiner GF, Joly AH, (2000) CTGF expression is induced by TGF- beta in cardiac fibroblasts and cardiac myocytes: a potential role in heart fibrosis. J Mol Cell Cardiol 32: 1805-1819.
4. Koitabashi N, Arai M, Niwano K, Watanabe A, Endoh M, et al. (2008) Plasma connective tissue growth factor is a novel potential biomarker of cardiac dysfunction in patients with chronic heart failure. Eur J Heart Fail 10: 373-379.
5. Shi-Wen X, Leask A, Abraham D, (2008) Regulation and function of connective tissue growth factor/CCN2 in tissue repair, scarring and fibrosis. Cytokine & growth factor reviews 19: 133-144.
6. Panek AN, Posch MG, Alenina N, Ghadge SK, Erdmann B, et al. (2009) Connective tissue growth factor overexpression in cardiomyocytes promotes cardiac hypertrophy and protection against pressure overload. PLoS ONE 4: e6743.
7. Ahmed MS, Gravning J, Martinov VN, von Lueder TG, Edvardsen T, et al. (2011) Mechanisms of novel cardioprotective functions of CCN2/CTGF in myocardial ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 300: H1291-1302.
8. Michael LH, Entman ML, Hartley CJ, Youker KA, Zhu J, et al. (1995) Myocardial ischemia and reperfusion: a murine model. Am J Physiol 269: H2147-2154.
9. Ørn S, Manhenke C, Greve OJ, Larsen AI, Bonarjee VV, et al. (2009) Microvascular obstruction is a major determinant of infarct healing and subsequent left ventricular remodelling following primary percutaneous coronary intervention. Eur Heart J 30: 1978-1985.
10. Bergestuen DS, Gravning J, Haugaa KH, Sahakyan LG, Aakhus S, et al. (2009) Plasma CCN2/connective tissue growth factor is associated with right ventricular dysfunction in patients with neuroendocrine tumors. BMC Cancer 10: 6.
11. Manhenke C, Ørn S, von Haehling S, Wollert KC, Ueland T, et al. (2011) Clustering of 37 circulating biomarkers by exploratory factor analysis in patients following complicated acute myocardial infarction. International journal of cardiology.
12. Ørn S, Manhenke C, Ueland T, Damas JK, Mollnes TE, et al. (2009) C-reactive protein, infarct size, microvascular obstruction, and left-ventricular remodelling following acute myocardial infarction. European heart journal 30: 1180-1186.
13. Lin J, Liliensiek B, Kanitz M, Schimanski U, Bohrer H, et al. (1998) Molecular cloning of genes differentially regulated by TNF-alpha in bovine aortic endothelial cells, fibroblasts and smooth muscle cells. Cardiovasc Res 38: 802-813.
14. Kempf T, von Haehling S, Peter T, Allhoff T, Cicoira M, et al. (2007) Prognostic utility of growth differentiation factor-15 in patients with chronic heart failure. J Am Coll Cardiol 50: 1054-1060.
15. Bergmann O, Bhardwaj RD, Bernard S, Zdunek S, Barnabe-Heider F, et al. (2009) Evidence for cardiomyocyte renewal in humans. Science 324: 98-102.
16. Gnecchi M, Zhang Z, Ni A, Dzau VJ, (2008) Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res 103: 1204-1219.
17. Tateishi K, Ashihara E, Honsho S, Takehara N, Nomura T, et al. (2007) Human cardiac stem cells exhibit mesenchymal features and are maintained through Akt/GSK-3beta signaling. Biochem Biophys Res Commun 352: 635-641.
18. Angert D, Berretta RM, Kubo H, Zhang H, Chen X, et al. (2011) Repair of the injured adult heart involves new myocytes potentially derived from resident cardiac stem cells. Circ Res 108: 1226-1237.
19. Stastna M, Chimenti I, Marban E, Van Eyk JE, (2010) Identification and functionality of proteomes secreted by rat cardiac stem cells and neonatal cardiomyocytes. Proteomics 10: 245-253.
20. Touvron M, Escoubet B, Mericskay M, Angelini A, Lamotte L, et al. (2012) Locally expressed IGF1 propeptide improves mouse heart function in induced dilated cardiomyopathy by blocking myocardial fibrosis and SRF-dependent CTGF induction. Disease models & mechanisms 5: 481-491.
21. Lakkisto P, Siren JM, Kyto V, Forsten H, Laine M, et al. (2011) Heme oxygenase-1 induction protects the heart and modulates cellular and extracellular remodelling after myocardial infarction in rats. Experimental biology and medicine 236: 1437-1448.
22. van Almen GC, Verhesen W, van Leeuwen RE, van de Vrie M, Eurlings C, et al. (2011) MicroRNA-18 and microRNA-19 regulate CTGF and TSP-1 expression in age-related heart failure. Aging cell 10: 769-779.
23. Gressner AM, Yagmur E, Lahme B, Gressner O, Stanzel S, (2006) Connective tissue growth factor in serum as a new candidate test for assessment of hepatic fibrosis. Clin Chem 52: 1815-1817.
24. Fonseca C, Lindahl GE, Ponticos M, Sestini P, Renzoni EA, et al. (2007) A polymorphism in the CTGF promoter region associated with systemic sclerosis. N Engl J Med 357: 1210-1220.
25. Wang B, Carter RE, Jaffa MA, Nakerakanti S, Lackland D, et al. (2010) Genetic variant in the promoter of connective tissue growth factor gene confers susceptibility to nephropathy in type 1 diabetes. J Med Genet 47: 391-397.